Literature DB >> 21242964

Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors.

M Dalvai1, O Mondesert, J-C Bourdon, B Ducommun, C Dozier.   

Abstract

Cdc25B phosphatases function as key players in G2/M cell cycle progression by activating the CDK1-cyclinB1 complexes. They also have an essential role in recovery from the G2/M checkpoint activated in response to DNA damage. Overexpression of Cdc25B results in bypass of the G2/M checkpoint and illegitimate entry into mitosis, and also causes replicative stress, leading to genomic instability. Thus, fine-tuning of Cdc25B expression level is critical for correct cell cycle progression and G2 checkpoint recovery. However, the transcriptional regulation of Cdc25B remains largely unknown. Earlier studies have shown that the tumor suppressor p53 overexpression transcriptionally represses Cdc25B; however, the molecular mechanism of this repression has not yet been elucidated, although it was suggested to occur through the induction of p21. Here we show that Cdc25B is downregulated by the basal level of p53 in multiple cell types. This downregulation also occurs in p21-/- cell lines, indicating that p21 is not required for p53-mediated regulation of Cdc25B. Deletion and mutation analyses of the Cdc25B promoter revealed that downregulation by p53 is dependent on the presence of functional Sp1/Sp3 and NF-Y binding sites. Furthermore, chromatin immunoprecipitation analyses show that p53 binds to the Cdc25B promoter and mediates transcriptional attenuation through the Sp1 and NF-Y transcription factors. Our results suggest that the inability to downregulate Cdc25B after loss of p53 might contribute to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242964     DOI: 10.1038/onc.2010.588

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Transcription factor NF-Y is a functional regulator of the transcription of core clock gene Bmal1.

Authors:  Jun Xiao; Yongchun Zhou; Hao Lai; Shi Lei; Lisa H Chi; Xianwei Mo
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

2.  Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines.

Authors:  Hélène Albert; Eric Battaglia; Carolino Monteiro; Denyse Bagrel
Journal:  Mol Oncol       Date:  2012-07-27       Impact factor: 6.603

3.  Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.

Authors:  Lakshmi Reddy Bollu; Jonathan Shepherd; Dekuang Zhao; Yanxia Ma; William Tahaney; Corey Speers; Abhijit Mazumdar; Gordon B Mills; Powel H Brown
Journal:  NPJ Breast Cancer       Date:  2020-01-03

4.  Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

Authors:  Joanna Zawacka-Pankau; Vera V Grinkevich; Sabine Hünten; Fedor Nikulenkov; Angela Gluch; Hai Li; Martin Enge; Alexander Kel; Galina Selivanova
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

5.  An LTR retrotransposon-derived lncRNA interacts with RNF169 to promote homologous recombination.

Authors:  Bing Deng; Wenli Xu; Zelin Wang; Chang Liu; Penghui Lin; Bin Li; Qiaojuan Huang; Jianhua Yang; Hui Zhou; Lianghu Qu
Journal:  EMBO Rep       Date:  2019-09-05       Impact factor: 8.807

Review 6.  DNA damage response genes and the development of cancer metastasis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

7.  Arabidopsis DPB3-1, a DREB2A interactor, specifically enhances heat stress-induced gene expression by forming a heat stress-specific transcriptional complex with NF-Y subunits.

Authors:  Hikaru Sato; Junya Mizoi; Hidenori Tanaka; Kyonosin Maruyama; Feng Qin; Yuriko Osakabe; Kyoko Morimoto; Teppei Ohori; Kazuya Kusakabe; Maika Nagata; Kazuo Shinozaki; Kazuko Yamaguchi-Shinozaki
Journal:  Plant Cell       Date:  2014-12-09       Impact factor: 11.277

8.  CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner.

Authors:  Ying-Chieh Chen; Hsi-Hsien Hsieh; Hsi-Chi Chang; Hsin-Chiao Wang; Wey-Jinq Lin; Jing-Jer Lin
Journal:  J Biol Chem       Date:  2021-03-18       Impact factor: 5.157

9.  The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.

Authors:  Peggy Benisch; Tatjana Schilling; Ludger Klein-Hitpass; Sönke P Frey; Lothar Seefried; Nadja Raaijmakers; Melanie Krug; Martina Regensburger; Sabine Zeck; Thorsten Schinke; Michael Amling; Regina Ebert; Franz Jakob
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

10.  Cloning and characterization of the human USP22 gene promoter.

Authors:  Jianjun Xiong; Xiangxin Che; Xueqin Li; Huan Yu; Zhen Gong; Weidong Li
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.